文献速递膀胱癌与上尿路尿路上皮癌

基于人群的膀胱癌登记研究的教训:探讨生存率为何未改善

Lessons from a population-based bladder cancer registry: exploring why survival is not improving.
PubMed 文献 · BJU Int · 2024-02-26

该研究从南澳大利亚癌症登记处提取1977年1月1日至2020年12月31日数据,分析8356例≥pT1期膀胱癌患者发病与生存变化。结果显示年龄标化发病率从1977年7.20/10万降至2020年5.85/10万,诊断平均年龄从68岁升至76岁,总生存下降(HR 1.22,95%CI 1.09-1.35),但校正诊断年龄后生存改善(HR 0.80,95%CI 0.76-0.94)。作者结论为过去40年侵袭性膀胱癌生存下降,人口年龄结构是重要因素。

要点

  • 侵袭性膀胱癌年龄标化发病率从1977年7.20/10万降至2020年5.85/10万。
  • 诊断平均年龄从68岁升至76岁,80岁及以上人群粗发病率每年增加3.3%(95%CI 2.1-4.6)。
  • 总生存下降(HR 1.22,95%CI 1.09-1.35),校正诊断年龄后生存改善(HR 0.80,95%CI 0.76-0.94)。

核心结论

  • 过去40年侵袭性膀胱癌生存率下降,人口年龄结构是重要促进因素。

研究设计与样本

  • 从南澳大利亚癌症登记处提取1977年1月1日至2020年12月31日数据,纳入8356例诊断≥pT1期疾病患者,探讨发病率和生存变化。

主要发现

  • 侵袭性膀胱癌年龄标化发病率从1977年7.20例/10万人降至2020年5.85例/10万人。
  • 诊断平均年龄从68岁增至76岁;80岁及以上患者粗发病率每年增加3.3%(95%CI 2.1-4.6)。
  • 研究期间总生存下降(HR 1.22,95%CI 1.09-1.35)。
  • 校正诊断年龄后生存改善(HR 0.80,95%CI 0.76-0.94)。
  • 尽管老年人非膀胱癌特异性死亡减少,老年人膀胱癌特异性死亡率无变化(HR 0.94,95%CI 0.70-1.26);男性与更高生存相关(HR 0.87,95%CI 0.83-0.92),社会经济优势与生存无关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore the causes of the decrease in bladder cancer survival that has occurred over the past four decades. METHODS: We extracted data from the South Australian Cancer Registry. Data from the period 1 January 1977 to 31 December 2020 were extracted to explore changes in incidence and survival among a total of 8356 patients diagnosed with ≥pT1 disease. Invasive bladder cancer was defined as ≥pT1 in this study. RESULTS: Invasive bladder cancer age-standardized incidence decreased from 7.20 cases per 100 000 people in 1977 to 5.85 cases per 100 000 in 2020. The mean age at diagnosis increased from 68 years to 76 years. The crude incidence for patients aged 80 years and over increased by 3.3% per year (95% confidence interval [CI] 2.1 to 4.6). Overall survival decreased over the study period (hazard ratio [HR] 1.22 [95% CI 1.09 to 1.35]), however, survival increased after adjusting for age at diagnosis (HR 0.80 [95% CI 0.76 to 0.94]). Despite a decrease in non-bladder cancer-specific deaths in older people, there was no change in the bladder cancer-specific death rate in older people (HR 0.94 [95% CI 0.70 to 1.26]). Male sex was associated with higher survival (HR 0.87 [95% CI 0.83 to 0.92]), whereas socioeconomic advantage was not. CONCLUSIONS: Invasive bladder cancer survival has decreased over the past 40 years, with the age structure of the population being a significant contributing factor. PATIENT SUMMARY: We looked at why bladder cancer survival is decreasing using a large cancer registry with information from 1977 to 2020. We found that people are now more likely to be diagnosed at an older age. Older people often live for a shorter time with bladder cancer compared to younger people. Bladder cancer survival has decreased because there are more older people with the disease than previously.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Tempo JA, Sii S, Ischia J, et al. Lessons from a population-based bladder cancer registry: exploring why survival is not improving. BJU Int. 2024. PMID: 38409928. doi:10.1111/bju.16286

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。